Huntx Pharma
French tech company | Builders Republic
About
Drug-discovery biotech developing oral small molecules to prevent the onset of inherited neurodegenerative diseases — targeting axonal-transport defects shared across genetic disorders, with a lead program for Huntington's disease, screened using brain-on-a-chip microfluidic devices.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2022
- City
- GRENOBLE
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 1.7 M€ raised since 2020
Funding rounds
- Seed — 2024